1702P Updated Results of Phase II Study of Cabozantinib (cabo) with Nivolumab (nivo) and Ipilimumab (ipi) in Advanced Renal Cell Carcinoma with Divergent Histologies (Rccdh)
Annals of Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology（2024）